Changes in SARS-CoV-2 Antibody Titers from Three to Nine Months after Administration of the BNT162b2 mRNA Vaccine among Healthcare Workers in Japan: A Prospective Study

Intern Med. 2022 Jul 1;61(13):2095. doi: 10.2169/internalmedicine.9695-22. Epub 2022 Apr 23.

Authors

Takeshi Mochizuki¹, Takaki Hori², Koichiro Yano³, Katsunori Ikari³, Ken Okazaki³

Affiliations

¹ Department of Rheumatology and Orthopedic Surgery, Kamagaya General Hospital, Japan.
² Department of Cardiovascular Surgery, Kamagaya General Hospital, Japan.
³ Department of Orthopedic Surgery, Tokyo Women's Medical University, Japan.

No abstract available

Keywords: Japan; SARS-CoV-2 antibody titer; healthcare workers; vaccine.

Publication types

Letter

MeSH terms

Antibodies, Viral
BNT162 Vaccine*
COVID-19* / prevention & control
Health Personnel
Humans
Japan
Prospective Studies
SARS-CoV-2
Vaccines, Synthetic
mRNA Vaccines

Substances

Antibodies, Viral
Vaccines, Synthetic
mRNA Vaccines
BNT162 Vaccine